M&T Bank’s Maravai LifeSciences MRVI Stock Holding History

M&T Bank’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84.2K	Sell	13,512 -346	-2%	-$1.49K	﹤0.01%	1714
2026 Q1	$38.8K	Buy	13,858 +51	+0.4%	+$173	﹤0.01%	1679
2025 Q4	$45.2K	Buy	+13,807	New	+$46.5K	﹤0.01%	1657
2024 Q4	–	Sell	-21,757	Closed	-$181K	–	1674
2024 Q3	$181K	Sell	21,757 -6,011	-22%	-$52K	﹤0.01%	1533
2024 Q2	$200K	Buy	27,768 +2,251	+9%	+$19.4K	﹤0.01%	1474
2024 Q1	$221K	Buy	25,517 +5,410	+27%	+$36.6K	﹤0.01%	1455
2023 Q4	$131K	Buy	20,107 +2,972	+17%	+$19.2K	﹤0.01%	1544
2023 Q3	$172K	Buy	17,135 +3,158	+23%	+$34.7K	﹤0.01%	1457
2023 Q2	$173K	Buy	13,977 +2,185	+19%	+$29.5K	﹤0.01%	1497
2023 Q1	$165K	Buy	+11,792	New	+$169K	﹤0.01%	1510

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

M&T Bank's MRVI Position: Q2 2026 in Review

M&T Bank reduced its Maravai LifeSciences (MRVI) stake by 2.5% in Q2 2026, selling an estimated $1.49K and leaving 13,512 shares worth $84.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1714.

M&T Bank first reported a position in MRVI in Q1 2023 and has held it in 10 quarters since. The position peaked at $221K in Q1 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

M&T Bank held 13,512 shares of Maravai LifeSciences worth $84.2K as of Q2 2026.
M&T Bank sold 346 Maravai LifeSciences shares in Q2 2026, an estimated $1.49K.
Maravai LifeSciences made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1714 holding.
M&T Bank first reported a position in Maravai LifeSciences in Q1 2023 and has held it in 10 quarters since.
M&T Bank's Maravai LifeSciences position peaked at $221K in Q1 2024.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.